MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 28 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,645,000 | +49.4% | 2,246,503 | 0.0% | 0.44% | +19.6% |
| Q2 2022 | $13,816,000 | -4.2% | 2,246,503 | 0.0% | 0.37% | +16.8% |
| Q1 2022 | $14,423,000 | -2.0% | 2,246,503 | 0.0% | 0.32% | +21.6% |
| Q4 2021 | $14,715,000 | +14.7% | 2,246,503 | 0.0% | 0.26% | +45.5% |
| Q3 2021 | $12,828,000 | +3.8% | 2,246,503 | 0.0% | 0.18% | -10.1% |
| Q2 2021 | $12,356,000 | -5.0% | 2,246,503 | 0.0% | 0.20% | +1.0% |
| Q1 2021 | $13,007,000 | -16.6% | 2,246,503 | -3.5% | 0.20% | -10.1% |
| Q4 2020 | $15,596,000 | -11.9% | 2,327,714 | -3.8% | 0.22% | -32.7% |
| Q3 2020 | $17,706,000 | – | 2,418,798 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |